文献速递糖尿病肥胖与代谢综合征

代谢健康与肥胖状态转变对慢性肾脏病发病的影响:一项全国性队列研究

Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

该观察性研究基于韩国国民健康保险服务-全国样本队列的514 866人,评估代谢健康肥胖(MHO)的纵向变化与慢性肾脏病(CKD)发病风险。基线MHO组CKD风险高于代谢健康非肥胖(MHNO)组(HR 1.23,95%CI 1.12-1.36),但转为MHNO者风险未增加(HR 0.98,95%CI 0.72-1.32);维持MHO或转为代谢不健康者风险升高。

要点

  • 基线MHO组CKD发病风险高于MHNO组(HR 1.23,95%CI 1.12-1.36)。
  • 转为MHNO者CKD风险未增加(HR 0.98,95%CI 0.72-1.32)。
  • 维持MHO或转为代谢不健康状态者CKD风险高于稳定MHNO组。

核心结论

  • MHO是一种动态状态,MHO人群构成异质性群体。
  • MHO表型总体与CKD发病相关,但维持代谢健康和减轻体重可能降低CKD风险。

研究设计与样本

  • 观察性研究,基于韩国国民健康保险服务-全国样本队列的514 866人。
  • 评估基线及随访中肥胖(依据体质指数[BMI]和腰围[WC])与代谢健康状态的初始存在及变化。
  • 主要结局为2011年至2015年新发CKD。

主要发现

  • 基线按BMI标准分类为MHO者中,47.6%在2011年和2012年仍为MHO,12.1%转为代谢健康非肥胖(MHNO),5.5%转为代谢不健康非肥胖,34.8%转为代谢不健康肥胖。
  • 基线MHO组CKD发病风险高于MHNO组(HR 1.23,95%CI 1.12-1.36)。
  • 考虑状态转变后,转为MHNO者风险未增加(HR 0.98,95%CI 0.72-1.32),而稳定MHO组及转为代谢不健康状态组CKD发病风险高于稳定MHNO组。
  • 按WC标准分析时,除稳定MHO组外,风险模式与BMI标准相似。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Metabolically healthy obesity (MHO) is a dynamic condition. OBJECTIVE: To evaluate the risk of chronic kidney disease (CKD) among people with MHO according to its longitudinal change. DESIGN: Observational study. SETTING: A nationwide population-based cohort. PARTICIPANTS: A total of 514 866 people from the Korean National Health Insurance Service-National Sample Cohort. INTERVENTION: The initial presence and changes of obesity (using body mass index [BMI] and waist circumference [WC]) and metabolic health status. MAIN OUTCOME MEASURE: Incident CKD from 2011 to 2015. RESULTS: Of the people classified as MHO at baseline (BMI criteria), 47.6% remained as MHO in 2011 and 2012, whereas 12.1%, 5.5%, and 34.8% were classified as metabolically healthy, non-obese (MHNO), metabolically unhealthy, non-obese, and metabolically unhealthy, obese, respectively. The risk of incident CKD in the baseline MHO group was higher than that in the MHNO group (hazard ratio, 1.23; 95% confidence interval, 1.12-1.36). However, when transition was taken into account, people who converted to MHNO were not at increased risk (hazard ratio, 0.98; 95% confidence interval, 0.72-1.32), whereas the stable MHO group and the groups that evolved to metabolically unhealthy status had a higher risk of incident CKD than the stable MHNO group. When the risk was analyzed using WC criteria, it showed a similar pattern to BMI criteria except for the stable MHO group. CONCLUSIONS: MHO was a dynamic condition, and people with MHO constituted a heterogeneous group. Although the MHO phenotype was generally associated with incident CKD, maintenance of metabolic health and weight reduction might alleviate the risk of CKD.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Cho YK, Lee J, Kim HS, et al. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study. J Clin Endocrinol Metab. 2020. PMID: 31967306. doi:10.1210/clinem/dgaa033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。